Bill > S148

This bill, the "Stop STALLING Act," aims to enable the Federal Trade Commission (FTC) to deter the filing of sham citizen petitions that attempt to interfere with the approval of competing generic drugs or biosimilars. The bill defines "sham" petitions as those that are objectively baseless and intended to use the governmental process to interfere with a competitor's business. The bill allows the FTC to bring civil actions against individuals or entities that submit or cause the submission of such sham petitions, and imposes civil penalties based on the revenue earned from the sale of any drug products referenced in the sham petitions or a fixed daily amount. The bill also provides that the FTC's authority under this act is in addition to, and not in lieu of, any other remedies available under federal law.